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Abstract 
Hiperglycaemia could induce endothelial dysfunction and one of a biomarker of it is vascular cell adhesion 
molecule-1 (VCAM-1), this study aims to analyze VCAM-1 level based on glycated hemoglobin (HbA1c) Level 
in type 2 diabetes mellitus patient. It was an observational study with cross-sectional design, population of study 
were type 2 diabetes mellitus patient underwent examination and treatment in the Internal Medicine Section dr 
Wahidin Sudirohusodo Hospital, Hasanuddin University Hospital,  Clinic and private Laboratory 123.  Sample 
taken by purposive sampling were 160 patients. Laboratory examination was done in the Clinical Pathology 
Laboratory of  dr Wahidin Sudirohusodo Hospital Makassar, Hasanuddin University, Prodia Clinic Laboratory 
and Biomolecular Laboratory of Medicine Faculty Hasanuddin University. Data presented as tables with 
frequency, percent, mean and deviation standard. Data Analysis using Mann-Whitney U test, mean difference 
was significance if probability value lower than 0.05. Patients were categorized as controlled and uncontrolled 
blood glucose levels based on HbA1c Level, if  HbA1c <7%, it was categorized as controlled diabetes mellitus 
patient and if HbA1c >7%, it was categorized as uncontrolled diabetes mellitus patient.  Results indicated that 
uncontrolled group (16.946 ng/ml) had higher VCAM-1 level compared to controlled group (19.080 ng/ml). 
Their differences were 2.134 ng/ml and it was significance statistically (p=0.000, p<0.05). Uncontrolled blood 
glucose level of type 2 diabetes mellitus patient will lead to increased VCAM-1 which will be a marker for 
endothelial failure and an increased risk of diabetes complications.  
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1. Introduction 
Endothelial dysfunction in diabetes mellitus increasesthe risk of complications such as cardiovascular disease   
because.  it contributes to the development of atherosclerosis  [1, 2].  Prevention of endothelial dysfunction is the 
target of therapy, especially diabetes mellitus type 2 [3]. One of the causa is hyperglycemia induced by 
oxidative stress, balancing between nitric oxide (NO) and oxidative stress is needed [4, 5]. Uncontrolled 
diabetes induced endothelial dysfunction that can be marked by increased vascular cell adhesion molecule-1 
(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) and this situation cause leukocyte adhesion to the 
endothelial surface,  under normal conditions balancing of NO prevent this adhesion. [1]. Endothelial 
dysfunction may also lead to more severe hyperglycemia [6]. Glycemic control is a key to reduce mortality in 
diabetes mellitus and hyperglycemis can be monitored through glycated hemoglobin (HbAic) measurements, 
HBA1c also a marker for complication and prognosis of diabetes [7]. It is recommended to monitor blood 
glucose level and indicated poor control of glycemic [8]. Uncontrolled diabetes can also be characterized by 
vascular adhesion molecule-1 (VCAM-1), it is expressed by endothelial cells and induced inflammation [9, 10]. 
This soluble adhesive molecule concentration is a predictor of cardiovascular risk  even a study revealed that 
VCAM-1 is not associated with macrovascular disease [11, 12].  This study aims to analyze VCAM-1 level 
based on HbA1c Level in type 2 diabetes mellitus patient. 
2. Material and Methods 
This study was an observational study with crosssectional design, population of study were type 2 diabetes 
mellitus patient underwent examination and treatment in the Internal Medicine Section dr.Wahidin 
Sudirohusodo Hospital, Hasanuddin University Hospital,  Clinic and private Laboratory 123.  Sample taken by 
purposive sampling were 160 patients. After getting ethical clearance from ethical commission of Medicine 
Faculty of Hasanuddin University, laboratory examination was done in the Clinical Pathology Laboratory of  dr. 
Wahidin Sudirohusodo Hospital Makassar, Hasanuddin University, Prodia Clinic Laboratory and Biomolecular 
Laboratory of Medicine Faculty Hasanuddin University. Data presented as tables with frequency, percent, mean 
and deviation standard. Data Analysis using Mann-Whitney U test, mean difference was significance if 
probability value lower than 0.05. 
3. Result 
Patients were categorized as controlled and uncontrolled blood glucose levels based on HbA1c Level, if  HbA1c 
<7%, it was categorized as controlled diabetes mellitus patient and if HbA1c >7%, it was categorized as 
uncontrolled diabetes mellitus patient.  
Table 1: The Distribution of Subject Based On Controlled And Uncontrolled Blood Glucose Levels 
Group Frequency (n) 
Percent 
(%) 
Controlled (HbA1c < 7%) 80 50 
Uncontrolled (HbA1c > 7%) 80 50 
Total 160 100 
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Table 1 indicated that both controlled and uncontrolled diabetes mellitus group were 80 (50%) patients  or 
frequency had same quantity. 
Table 2: Mean Comparison of VCAM-1 Between Groups 
Group 
VCAM-1 Level 
(ng/ml) 
Mean±SD 
Mean 
Differences 
(ng/ml) 
P 
 
Controlled (HbA1c < 7%) 16.946±17.120 2.134  0.000*  
Uncontrolled (HbA1c > 7%) 19.080±29.019 
                           *Mann-Whitney U Test 
Table 2 indicated that uncontrolled group (16.946 µg/l) had higher VCAM-1 level compared to controlled group 
(19.080 ng/ml). Their differences was 2.134 ng/ml and it was signicance statistically (p=0.000, p<0.05).  
4. Discussion 
Result of studi indicated VCAM-1 was significantly higher in patients with type 2 diabetes mellitus who had an 
elevated HbA1c level of more than 7 percent (uncontrolled diabetes patient) compared with patients with 
HbA1c levels below 7 percent (Controlled diabetes patient). This increase indicates the presence of endothelial 
dysfunction which is an indication that there has been an imbalance in the regulation of the inflammatory 
process. The increase in VCAM-1 being one of the endothelial dysfunction biomarkers suggests that HbA1c 
levels that mark the control of blood glucose for diabetics should be of concern because of  strong association 
between endothelial dysfunction and hyperglycaemia. This condition will increase the risk of major diabetes 
complications that need to be feared is cardiovascular due to the formation of plaque leading to atheosclerosis 
because leukocyte adhesion in the endothelium [9, 11]. In addition to cardiovascular disease, complications of 
diabetic retinopathy and nephropathy also pose a risk to increased hyperglycaemia-induced VCAM-1 [13, 14]. 
Hyperglycaemia increases the formation of advanced glycation end products (AGE) that trigger endothelial 
dysfunction due to NO imbalances [15].  This study corroborates the previous studies that VCAM-1 will 
increase in uncontrolled diabetes conditions 
5. Conclusion 
Uncontrolled blood glucose level of type 2 diabetes mellitus patient will lead to increased VCAM-1 which will 
be a marker for endothelial failure and an increased risk of diabetes complications.  
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